MRI in head and neck tumours

  • Dr.Rabindran Chandran Consultant, Neonatologist, Billroth Hospital, Chennai, India
  • Dr D Sharad Gedam Professor of Pediatrics, RKDF Medical college, Bhopal, MP, India
Keywords: Head and neck tumours, Functional MRI, Diffusion Weighted -MRI

Abstract

Head and neck cancer are prevalent reason for cancer. Compared to CT, MRI has better tissue, spatial and contrast resolution, Non-ionizing radiation, Non-invasiveness, Multiplanar imaging and soft tissue definition.

Downloads

Download data is not yet available.

References

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: https://doi.org/10.3322/caac.20107.

Razek AA, Tawfik AM, Elsorogy LG, Soliman NY. Perfusion CT of head and neck cancer. Eur J Radiol. 2014 Mar;83(3):537-44. doi: https://doi.org/10.1016/j.ejrad.2013.12.008. Epub 2013 Dec 16.

Gaddikeri S, Gaddikeri RS, Tailor T, Anzai Y.DynamicContrast-EnhancedMRImaging in Head and Neck Cancer: Techniques and Clinical Applications. AJNR Am J Neuroradiol.2016 Apr;37(4):588-95. doi: https://doi.org/10.3174/ajnr.A4458. Epub 2015 Oct 1.

SiezaSamir, Mohamed AliEl-Adalany, Emad EldeenHamed. Value of dynamic contrast enhanced magnetic resonance imaging in the differentiation between post-treatment changes and recurrent salivary gland tumors. The Egyptian Journal of Radiology and Nuclear Medicine. Volume 47, Issue 2, June 2016, Pages 477-486. doi: https://doi.org/10.1016/j.ejrnm.2016.01.005.

Krishna MC, Subramanian S, Kuppusamy P, Mitchell JB. Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration. SeminRadiatOncol. 2001 Jan;11(1):58-69.

Li XS, Fan HX, Fang H, Song YL, Zhou CW. Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy. J MagnReson Imaging. 2015 Sep;42(3):681-8. doi: https://doi.org/10.1002/jmri.24837.

Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996 Jan;17(1):1-15.

Markkola AT, Aronen HJ, Lukkarinen S, Ramadan UA, Tanttu JI, Sepponen RE.Multiple-slicespinlockimaging of head and necktumors at 0.1Tesla: exploringappropriateimagingparameters with reference to T2-weightedspin-echotechnique.Invest Radiol.2001 Sep;36(9):531-8.

Ward KM, Aletras AH, Balaban RS. A newclass of contrast agents for MRIbased on protonchemicalexchangedependentsaturationtransfer (CEST). J Magn Reson.2000 Mar;143(1):79-87.

Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, Tyler B, Blakeley J, Laterra J, vanZijlPC.Differentiationbetweengliomaandradiationnecrosisusingmolecularmagnetic resonance imagingofendogenousproteinsandpeptides. Nat Med.2011Jan;17(1):130-4. doi: https://doi.org/10.1038/nm.2268. Epub 2010 Dec 19.

MRI in head and neck tumours
CITATION
DOI: 10.17511/ijmrr.2017.i12.01
Published: 2017-12-31
How to Cite
1.
Chandran R, Gedam DS. MRI in head and neck tumours. Int J Med Res Rev [Internet]. 2017Dec.31 [cited 2024Nov.22];5(12):974-5. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/942
Section
Editorial